Trade

Valiant Laboratories share price

High risk
  • 60%Low risk
  • 60%Moderate risk
  • 60%Balanced risk
  • 60%High risk
  • 60%Extreme risk
  • 62.22(0.03%)
    July 10, 2026 15:16:42 PM IST
    • NSE
    • BSE
  • Vol : 16.53 K (NSE + BSE)
    Last 20 day avg : 22.43 K
Valiant Laboratories is trading 0.03% upper at Rs 62.22 as compared to its last closing price. Valiant Laboratories has been trading in the price range of 63.00 & 62.22. Valiant Laboratories has given -11.20% in this year & -4.09% in the last 5 days. The company posted a net profit of 1.76 Crores in its last quarter.Listed peers of Valiant Laboratories include Sun Pharmaceutical Industries (-0.19%), Divi's Laboratories (0.31%), Torrent Pharmaceuticals (-0.03%).The Mutual Fund holding in Valiant Laboratories was at -% in . The MF holding has - from the last quarter. The FII holding in Valiant Laboratories was at 0.20% in 31 Mar 2026. The FII holding has increased from the last quarter.
  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on Jul 10, 2026, 02:42 PM UTC

  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.15
    Higher than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.00
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    1.12
    Lower than historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    -
  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    -
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
62.22
Highest
63.00
52 week range
Lowest
50.00
Highest
114.72
Valiant Laboratories Peers
Return Comparison
Peers Comparison
Names
Price%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Sun Pharmaceutical Industries
1,935.25-0.194,64,320.3634.535.51.000.50
Divi's Laboratories
6,832.300.311,81,268.3274.0110.850.490.01
Torrent Pharmaceuticals
4,895.20-0.031,65,669.1672.9618.530.8417.62
Lupin
2,496.90-0.241,14,082.0731.886.190.5111.80
Dr Reddy's Laboratories
1,245.50-1.911,03,954.0118.133.060.652.34
Valiant Laboratories Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2026-05-14Audited Results
2026-02-11Quarterly Results
2025-11-11Quarterly Results
2025-08-08Quarterly Results
2025-07-09Others
About the company Valiant Laboratories
  • IndustryBiotechnology & Drugs
  • ISININE0JWS01017
  • BSE Code543998
  • NSE CodeVALIANTLAB
Valiant Laboratories Limited is an India-based pharmaceutical ingredient manufacturing company. The Company is focused on manufacturing a Paracetamol active pharmaceutical ingredient (API)/bulk drug. It has several applications in the treatment of conditions such as headache, muscle ache, arthritis, backache, toothache, cold and fever. It is also used in the management of severe pain such as post-surgical and cancer pain. It operates a single-location manufacturing facility on the Tarapur industrial estate.
  • Management Info
  • Paresh ShahChief Financial Officer, Whole-Time Director
  • Akshay GangurdeCompliance Officer, Company Secretary
  • Santosh VoraManaging Director, Executive Director
Valiant Laboratories Share Price FAQs

Valiant Laboratories is trading at 62.22 as on Fri Jul 10 2026 09:46:42. This is 0.03% upper as compared to its previous closing price of 62.20.

The market capitalization of Valiant Laboratories is 337.93 Cr as on Fri Jul 10 2026 09:46:42.

The 52 wk high for Valiant Laboratories is 114.72 whereas the 52 wk low is 50.00

Valiant Laboratories can be analyzed on the following key metrics -

  • TTM P/E:
  • Sector P/E: 26.80
  • Dividend Yield: 0.00%
  • D/E ratio: 0.15

Valiant Laboratories reported a net profit of -3.27 Cr in 2026.